VerImmune Revenue and Competitors

Location

$10M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • VerImmune's estimated annual revenue is currently $1.2M per year.(i)
  • VerImmune's estimated revenue per employee is $77,500
  • VerImmune's total funding is $10M.

Employee Data

  • VerImmune has 16 Employees.(i)
  • VerImmune grew their employee count by 33% last year.

VerImmune's People

NameTitleEmail/Phone
1
Founding CEO & PresidentReveal Email/Phone
2
Head CMCReveal Email/Phone
3
Head CMCReveal Email/Phone
4
Associate Scientist I (Preclinical process development)Reveal Email/Phone
5
Scientist, Non-clinicalReveal Email/Phone
6
Executive Business AdvisorReveal Email/Phone
7
Senior Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.4M4837%N/AN/A
#2
$0.5M7-22%N/AN/A
#3
$19.2M12441%N/AN/A
#4
$1.4M950%N/AN/A
#5
$1.2M1633%$10MN/A
#6
$5.9M3815%N/AN/A
#7
$144.5M9329%N/AN/A
#8
$0.8M5400%N/AN/A
#9
$1.4M950%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is VerImmune?

VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer

keywords:N/A

$10M

Total Funding

16

Number of Employees

$1.2M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M16-41%$32.5M
#2
$1.9M167%N/A
#3
$3.5M160%N/A
#4
$3.5M16-20%N/A
#5
$1.7M16-11%N/A